Metraipolis › archive › dc_a529e2082269

Prognostic significance of ypN status after neoadjuvant chemoimmunotherapy in resectable NSCLC: a systematic review and meta-analysis — Europe PMC PMID:42255205

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42255205
DOI
10.3389/fonc.2026.1842157
License (as archived)
solo-consultazione
Archived
2026-11-01T08:48:50.862Z
SHA-256 of the archived text
c66f140dd84f97c2da045863bf3684a64cc0be271a65ba0d1a0dba45c9929067
Stable URL of this page
https://metraipolis.com/documento/dc_a529e2082269

How to cite

Prognostic significance of ypN status after neoadjuvant chemoimmunotherapy in resectable NSCLC: a systematic review and meta-analysis — Europe PMC PMID:42255205 — Europe PMC (en), https://europepmc.org/article/MED/42255205 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a529e2082269 (Metraipolis archive dc_a529e2082269, sha256 c66f140dd84f97c2da045863bf3684a64cc0be271a65ba0d1a0dba45c9929067)
BibTeX
@misc{dca529e2082269,
  title = {Prognostic significance of ypN status after neoadjuvant chemoimmunotherapy in resectable NSCLC: a systematic review and meta-analysis — Europe PMC PMID:42255205},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42255205},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a529e2082269; sha256 c66f140dd84f97c2da045863bf3684a64cc0be271a65ba0d1a0dba45c9929067},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42255205. Agents can read the archived copy with the MCP tool read_document.